In contrast, SRPK1 modulates alternative splicing of VEGF pre-mRNA, which leads to excessive angiogenesis in patients with Denys-Drash Syndrome harboring a mutation of the tumor suppressor gene WT1 [35]. Here, SRPK1 is linked to Denys-Drash syndrome.